TipRanks
Clearfield (CLFD)
NASDAQ:CLFD
Want to see CLFD full AI Analyst Report?

Clearfield (CLFD) AI Stock Analysis

559 Followers

Top Page

CLFD

Clearfield

(NASDAQ:CLFD)

Select Model
Select Model
Select Model
Neutral 52 (OpenAI - Gpt-5.6Sol)
Rating:52Neutral
Price Target:
$33.00
▲(12.05% Upside)
Action:Reiterated
Date:09/07/26
CLFD’s score is primarily held back by pressured financial performance (step-down in revenue versus prior-cycle peaks and recent losses) and weak technical momentum (below key moving averages with negative MACD). Offsetting these, the company’s low-leverage balance sheet provides resilience, and the recent credit facility extension adds modest liquidity flexibility, but valuation is challenged by negative earnings (negative P/E).
Positive Factors
Low Leverage
Very low leverage and sizable equity give Clearfield financial resilience during softer demand. Limited debt obligations preserve flexibility to fund operations, absorb volatility, and pursue recovery without the same refinancing or interest burden faced by more highly leveraged competitors.
Negative Factors
Revenue Contraction
Revenue has fallen substantially from the 2022–2023 peak and continued declining into the latest TTM period. This contraction signals weaker customer deployment activity or order volumes, reducing operating scale and making it harder for Clearfield to cover costs and rebuild durable earnings.
Read all positive and negative factors
Positive Factors
Negative Factors
Low Leverage
Very low leverage and sizable equity give Clearfield financial resilience during softer demand. Limited debt obligations preserve flexibility to fund operations, absorb volatility, and pursue recovery without the same refinancing or interest burden faced by more highly leveraged competitors.
Read all positive factors

Clearfield Key Performance Indicators (KPIs)

Any
Any
Net Revenue by Geography
Net Revenue by Geography
Shows how much revenue comes from each region, revealing where Clearfield’s sales growth and customer concentration live. Geographic splits highlight exposure to U.S. broadband funding cycles, international carrier demand, and currency or trade risks that can amplify or dampen future top-line growth.
Chart InsightsClearfield’s revenue is almost entirely U.S.-driven, with the 'Other' bucket showing episodic, one‑off spikes—recent collapse to near zero underlines that international/other receipts are lumpy and not a sustainable revenue offset. That concentration magnifies exposure to domestic program timing (BEAD delays) even as a 39% backlog jump and 1.3 book-to-bill support management’s FY26 sales cadence; investors should treat mid‑2026 strength as backlog conversion rather than durable geographic diversification, keeping an eye on margins and BEAD timing for true upside in 2027.
Data provided by:The Fly

Clearfield (CLFD) vs. SPDR S&P 500 ETF (SPY)

Clearfield Business Overview & Revenue Model

Company Description
Clearfield, Inc. specializes in the development, manufacturing, and global distribution of both standard and customized passive fiber optic connectivity solutions. These products cater to a diverse clientele, including entities engaged in fiber-to...
How the Company Makes Money
Clearfield primarily makes money by selling fiber optic connectivity, distribution, and management hardware to customers building or upgrading broadband and communications networks. Revenue is generated mainly from product sales (recognized when p...

Clearfield Earnings Call Summary

Earnings Call Date:May 06, 2026
(Q2-2026)
|
% Change Since: |
Next Earnings Date:Nov 05, 2026
Earnings Call Sentiment Neutral
The call presented a mixed picture: management delivered Q2 sales toward the high end of guidance, showed meaningful sequential backlog growth (+39%) and maintained a strong balance sheet ($147M cash, no debt) while continuing share repurchases. They also highlighted product momentum (NOVA) and a clear strategy to expand into adjacent edge and data center markets. Offsetting these positives are a 15% year-over-year revenue decline, a Q2 net loss (EPS down to -$0.04 from +$0.18 prior year), margin compression (gross margin down ~1.9 percentage points YoY), and significant uncertainty from BEAD funding delays that push meaningful program-related revenue into Fiscal 2027. Overall, the company appears well-capitalized and strategically positioned for longer-term growth, but near-term revenue and profitability are under pressure due to external program timing and supply/financing constraints.
Positive Updates
Q2 Sales Met Guidance and Forward Revenue Guidance Raised
Net sales of $34.4M came in toward the high end of guidance ($32M–$35M). Management provided Q3 guidance of $42M–$46M and reiterated full-year Fiscal 2026 guidance of $160M–$170M (≈10% top-line growth at the midpoint).
Negative Updates
Year-over-Year Revenue Decline
Q2 net sales of $34.4M represent a 15% decline versus $40.6M in the prior-year second quarter; part of the decline attributed to a prior-year pull-in by a Large Regional Customer.
Read all updates
Q2-2026 Updates
Negative
Q2 Sales Met Guidance and Forward Revenue Guidance Raised
Net sales of $34.4M came in toward the high end of guidance ($32M–$35M). Management provided Q3 guidance of $42M–$46M and reiterated full-year Fiscal 2026 guidance of $160M–$170M (≈10% top-line growth at the midpoint).
Read all positive updates
Company Guidance
Management guided Q3 FY2026 net sales of $42–$46 million and net income per diluted share of $0.17–$0.21 (based on shares outstanding at the end of Q2, excluding potential future repurchases), with operating expenses expected to remain roughly consistent with Q2; for full-year FY2026 they reiterated net sales of $160–$170 million (about 10% midpoint growth) and net income per share of $0.48–$0.62, with operating expenses as a percent of revenue in line with FY2025. For context, Q2 results included net sales of $34.4 million (near the high end of their $32–$35 million guidance), a gross margin of 32.5% (down from 34.4% year‑over‑year), operating expenses of $13.2 million, a net loss of $0.5 million (‑$0.04 per diluted share), a 39% sequential backlog increase and a 1.3 book‑to‑bill, about $147 million in cash and investments with no debt, and 237,000 shares repurchased for $7.3 million; management expects meaningful BEAD-related revenue in FY2027 while seeing healthy privately financed build activity in FY2026.

Clearfield Financial Statement Overview

Summary
Fundamentals are mixed: the balance sheet is a clear strength (low leverage and sizable equity), but operating performance has weakened materially versus 2022–2023 with volatile revenue and recent net losses. Cash flow is supportive in recent annual periods but inconsistent, and the unusually large TTM cash-flow figures reduce confidence in the latest cash signal.
Income Statement
42
Neutral
Balance Sheet
78
Positive
Cash Flow
55
Neutral
BreakdownTTMSep 2025Sep 2024Sep 2023Sep 2022Sep 2021
Income Statement
Total Revenue130.18M150.13M125.57M225.72M270.88M140.76M
Gross Profit49.42M50.54M25.85M79.86M112.95M61.18M
EBITDA14.29M14.79M-5.84M48.83M67.23M28.04M
Net Income-7.22M-8.05M-12.45M32.53M49.36M20.33M
Balance Sheet
Total Assets267.09M306.17M315.27M355.52M229.13M125.91M
Cash, Cash Equivalents and Short-Term Investments101.22M105.98M128.97M168.11M22.45M23.59M
Total Debt10.28M8.76M13.52M16.48M36.85M2.53M
Total Liabilities21.17M50.01M39.51M40.35M81.55M22.09M
Stockholders Equity245.92M256.16M275.76M315.16M147.58M103.82M
Cash Flow
Free Cash Flow17.62M24.71M12.66M11.63M-8.15M8.86M
Operating Cash Flow20.06M29.45M22.22M20.01M1.00M10.90M
Investing Cash Flow-15.36M-8.84M-6.90M-112.25M-8.20M-13.60M
Financing Cash Flow-17.22M-14.24M-36.91M113.42M10.65M-536.00K

Clearfield Technical Analysis

Technical Analysis Sentiment
Negative
Last Price29.45
Price Trends
50DMA
30.10
Positive
100DMA
33.12
Negative
200DMA
32.50
Negative
Market Momentum
MACD
0.12
Positive
RSI
46.98
Neutral
STOCH
17.18
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CLFD, the sentiment is Negative. The current price of 29.45 is below the 20-day moving average (MA) of 31.76, below the 50-day MA of 30.10, and below the 200-day MA of 32.50, indicating a neutral trend. The MACD of 0.12 indicates Positive momentum. The RSI at 46.98 is Neutral, neither overbought nor oversold. The STOCH value of 17.18 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for CLFD.

Clearfield Risk Analysis

Clearfield disclosed 23 risk factors in its most recent earnings report. Clearfield reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Clearfield Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
71
Outperform
$4.05B16.5118.87%0.19%9.44%11.37%
67
Neutral
$2.24B46.206.54%―27.84%―
62
Neutral
$115.39M44.4111.50%2.58%13.86%―
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
58
Neutral
$52.87B66.424.55%1.80%13.04%-24.13%
52
Neutral
$415.67M-59.50-2.90%―-27.40%-2843.33%
46
Neutral
$523.93M-19.86-18.82%4.42%15.75%78.71%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
CLFD
Clearfield
29.31
-5.89
-16.73%
ADTN
Adtran
6.58
-2.75
-29.47%
BDC
Belden
105.35
-12.62
-10.70%
CALX
Calix
36.08
-23.44
-39.38%
NOK
Nokia
9.02
3.52
64.06%
OCC
Optical Cable
13.13
4.63
54.47%

Clearfield Corporate Events

Business Operations and StrategyPrivate Placements and Financing
Clearfield Extends Credit Line Maturity for Flexibility
Positive
Jul 28, 2026
On July 24, 2026, Clearfield, Inc. amended its existing loan agreement with Old National Bank, extending the maturity date of its line of credit from July 24, 2026 to November 21, 2026. The amendment, which leaves all other material terms unchange...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 07, 2026